Cargando…

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration

Primary 4‐repeat tauopathies with frontotemporal lobar degeneration (FTLD) like Progressive Supranuclear Palsy (PSP) or Corticobasal Degeneration (CBD) show diverse cellular pathology in various brain regions. Besides shared characteristics of neuronal and oligodendroglial cytoplasmic inclusions of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briel, Nils, Pratsch, Katrin, Roeber, Sigrun, Arzberger, Thomas, Herms, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412068/ https://www.ncbi.nlm.nih.gov/pubmed/33089580 http://dx.doi.org/10.1111/bpa.12914

Ejemplares similares

Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2022)

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
por: Lamb, Ruth, et al.
Publicado: (2016)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

Distinct subcortical tau burden: The tau pallido‐claustral ratio separates progressive supranuclear palsy and corticobasal degeneration
por: Zhao, Chelsey ShengQi, et al.
Publicado: (2021)

Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX-
por: Uchihara, Toshiki, et al.
Publicado: (2016)

A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome
por: Chung, Eun Joo, et al.
Publicado: (2022)

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
por: Parmera, Jacy Bezerra, et al.
Publicado: (2022)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

The Small Heat Shock Protein HSP25/27 (HspB1) Is Abundant in Cultured Astrocytes and Associated with Astrocytic Pathology in Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Schwarz, Lisa, et al.
Publicado: (2010)

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2015)

Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2021)

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy
por: Tse, Nga Yan, et al.
Publicado: (2020)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

MAPT ‐Associated Familial Progressive Supranuclear Palsy with Typical Corticobasal Degeneration Neuropathology: A Clinicopathological Report
por: Cullinane, Patrick W., et al.
Publicado: (2023)

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Swallow, Diane M.A., et al.
Publicado: (2022)

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study
por: Zhang, Yu, et al.
Publicado: (2016)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant
por: Ling, H, et al.
Publicado: (2014)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
por: Dodich, Alessandra, et al.
Publicado: (2019)

Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
por: Whiteside, David J., et al.
Publicado: (2023)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2023)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome
por: Jatale, Vinayak, et al.
Publicado: (2023)

Accurate digital quantification of tau pathology in progressive supranuclear palsy
por: Pansuwan, Tanrada, et al.
Publicado: (2023)

Novel tau filament fold in corticobasal degeneration
por: Zhang, Wenjuan, et al.
Publicado: (2020)

Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration
por: Martínez-Maldonado, Alejandra, et al.
Publicado: (2021)

The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis
por: Lyons, Shane, et al.
Publicado: (2023)

Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
por: Uchida, Wataru, et al.
Publicado: (2023)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020)

Neurophysiological consequences of synapse loss in progressive supranuclear palsy
por: Adams, Natalie E, et al.
Publicado: (2022)

Towards accurate and unbiased imaging-based differentiation of Parkinson’s disease, progressive supranuclear palsy and corticobasal syndrome
por: Correia, Marta M, et al.
Publicado: (2020)

Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool
por: Peterson, Katie A., et al.
Publicado: (2021)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24c2h5fi7p14vkj15i77rq3pcj